BC Platforms named Advanced Drug Development Technology Of The Year in Europe 2026
BC Platforms has been recognized by Pharma Tech Outlook Europe for leadership in evidence generation and AI-enabled drug development.
BC Platforms has been recognized by Pharma Tech Outlook Europe for leadership in evidence generation and AI-enabled drug development.
A new article by Narasimha Kumar, published in MedCity News, explores why “AI in drug development is not a data problem, it’s an evidence problem.” The article examines how the challenge is no longer collecting data, but preserving the context, meaning, and relationships that transform data into usable evidence. Kumar argues that AI cannot reliably
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
Federated learning with the Flower Framework is available within BC Platforms’ trusted research environments.
BC Platforms signs a Strategic Collaboration Agreement with AWS to scale secure, AI-powered research environments.
A closer look at how RWD, analytics, and AI are reshaping standard of care insights and evidence generation across the drug lifecycle.